8-41672338-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000037.4(ANK1):c.5096+16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.996 in 1,613,436 control chromosomes in the GnomAD database, including 799,783 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.98 ( 72868 hom., cov: 32)
Exomes 𝑓: 1.0 ( 726915 hom. )
Consequence
ANK1
NM_000037.4 intron
NM_000037.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.169
Genes affected
ANK1 (HGNC:492): (ankyrin 1) Ankyrins are a family of proteins that link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 1, the prototype of this family, was first discovered in the erythrocytes, but since has also been found in brain and muscles. Mutations in erythrocytic ankyrin 1 have been associated in approximately half of all patients with hereditary spherocytosis. Complex patterns of alternative splicing in the regulatory domain, giving rise to different isoforms of ankyrin 1 have been described. Truncated muscle-specific isoforms of ankyrin 1 resulting from usage of an alternate promoter have also been identified. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 8-41672338-A-G is Benign according to our data. Variant chr8-41672338-A-G is described in ClinVar as [Benign]. Clinvar id is 261315.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-41672338-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.993 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.978 AC: 148768AN: 152166Hom.: 72816 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
148768
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.993 AC: 247996AN: 249630 AF XY: 0.995 show subpopulations
GnomAD2 exomes
AF:
AC:
247996
AN:
249630
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.997 AC: 1457383AN: 1461150Hom.: 726915 Cov.: 51 AF XY: 0.998 AC XY: 725257AN XY: 726912 show subpopulations
GnomAD4 exome
AF:
AC:
1457383
AN:
1461150
Hom.:
Cov.:
51
AF XY:
AC XY:
725257
AN XY:
726912
show subpopulations
African (AFR)
AF:
AC:
30928
AN:
33466
American (AMR)
AF:
AC:
44470
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
26004
AN:
26134
East Asian (EAS)
AF:
AC:
39693
AN:
39696
South Asian (SAS)
AF:
AC:
86081
AN:
86242
European-Finnish (FIN)
AF:
AC:
53045
AN:
53046
Middle Eastern (MID)
AF:
AC:
5735
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1111362
AN:
1111702
Other (OTH)
AF:
AC:
60065
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
195
390
586
781
976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.978 AC: 148880AN: 152286Hom.: 72868 Cov.: 32 AF XY: 0.979 AC XY: 72861AN XY: 74458 show subpopulations
GnomAD4 genome
AF:
AC:
148880
AN:
152286
Hom.:
Cov.:
32
AF XY:
AC XY:
72861
AN XY:
74458
show subpopulations
African (AFR)
AF:
AC:
38380
AN:
41558
American (AMR)
AF:
AC:
15167
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
AC:
3456
AN:
3472
East Asian (EAS)
AF:
AC:
5162
AN:
5162
South Asian (SAS)
AF:
AC:
4817
AN:
4822
European-Finnish (FIN)
AF:
AC:
10618
AN:
10618
Middle Eastern (MID)
AF:
AC:
288
AN:
294
European-Non Finnish (NFE)
AF:
AC:
68004
AN:
68034
Other (OTH)
AF:
AC:
2076
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
163
326
490
653
816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3455
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary spherocytosis type 1 Benign:4
Oct 09, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.